News Eli Lilly and Company London S.E.

Equities

LEL

US5324571083

Market Closed - London S.E. Other stock markets 14:37:36 10/12/2021 GMT			5-day change	1st Jan Change
225.3 ^CHF	-1.50%		-58.28%	-58.28%

06-28	Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	MT
06-28	EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	06-28	MT
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	06-28	RE
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	06-27	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	06-27	AQ
Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors	06-25	CI
Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	06-25	MT
Eli Lilly Working With OpenAI to Develop Medicines Against Drug-Resistant Pathogens	06-25	DJ
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria	06-25	MT
Eli Lilly: collaboration agreement with OpenAI	06-25	CF
Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria	06-25	MT
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	06-25	PR
Out with AI, in with defensive stocks	06-25
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	06-25	DJ
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	06-25
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating	06-25	MT
Trending : Lilly Anti-Obesity Drug Tirzepatide Reduces Sleep Apnea Severity in Studies	06-24	DJ
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing	06-24	RE
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	06-24	DJ
Doctors must keep Ozempic prescriptions in check, Danish regulator says	06-24	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm